Bryn Pharma, Inc. research brief
CIK 1746919
Generated Nov. 19, 2026, 5:36 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: LEBANON New Jersey. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Aug. 14, 2025 · D · 0001746919-25-000007 · Source evidence
Reported offering amount: 4692830 USD. Reported amount sold: 4692830 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Bryn Pharma, Inc. research brief,” CIK 1746919, retrieved Nov. 19, 2026, 5:36 a.m.. Cite the specific accessions used. No amounts have been summed.